| Company Name: |
Boao Pike |
| Tel: |
010-57798038 15652371397 |
| Email: |
lyn@biopike.com.cn |
|
| | ent-8-iso-15(S)-Prostaglandin F2α-d9 Basic information |
| | ent-8-iso-15(S)-Prostaglandin F2α-d9 Chemical Properties |
| solubility | DMF: 100 mg/ml
DMSO: 100 mg/ml
Ethanol: 100 mg/mlPBS (pH 7.2): 1 mg/ml |
| | ent-8-iso-15(S)-Prostaglandin F2α-d9 Usage And Synthesis |
| Description | ent-8-iso-15(S)-Prostaglandin F2α-d9 (ent-8-iso-15(S)-epi-PGF2α-d9) is intended for use as an internal standard for the quantification of ent-8-iso-15(S)-PGF2α (Item No. 10010380) by GC- or LC-MS. Isoprostanes are produced by the non-enzymatic, free radical peroxidation of phospholipid-esterified arachidonic acid. They have been used as biomarkers of oxidative stress, but they also have been found to have potent biological activity. ent-8-iso-15(S)-PGF2α is a potent vasoconstrictor of porcine retinal and brain microvessels with EC50 values of 15 and 24 nM, respectively. 1 This isoprostane is about ten-fold more potent than 8-iso-PGF2α in a whole blood platelet aggregation inhibition assay.2WARNING This product is not for human or veterinary use. | | References | [1] XIN HOU . Isomer-specific contractile effects of a series of synthetic F2-isoprostanes on retinal and cerebral microvasculature[J]. Free Radical Biology and Medicine, 2004, 36 2: Pages 163-172. DOI: 10.1016/j.freeradbiomed.2003.10.024
[2] M. SHIZUKA M S. Selective synthesis of ent -15 -epi -F2t-isoprostane and a deuterated derivative[J]. Synthesis-Stuttgart, 2007, 74 1: 2397-2403. DOI: 10.1055/s-2007-983768 |
| | ent-8-iso-15(S)-Prostaglandin F2α-d9 Preparation Products And Raw materials |
|